Servier and Cure51 launch a research partnership to uncover new therapeutic targets in glioblastoma and develop new treatments derived from long term survivors’ biology
Newsroom
NEWS
All our latest news
Servier expands its Golden Ticket program to China
Therapeutic adherence at the forefront of the new #BecauseISaySo campaign
IN DEPTH
All our latest decrypts
Understanding clinical trials
Venous disease: when the circulatory system is affected
Understanding Hypertension
#weareservier
Our employees are committed
Sarah’s story, Senior Clinical Operations Project Manager, Australia
Paula’s story, Medical Representative, Colombia
Élodie’s story, Organic & Medicinal Chemistry Technician, France